JUDY NEWMAN , 608-252-6156 Aug 31, 2014 Aug 31, 2014 0 Exact Sciences’ spanking clean, new labs in the Novation Campus, off Rimrock Road, sit waiting for the rush to begin. Their mission: to examine ...
Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.
What if you didn't have to get a colonoscopy every decade from ages 45 to 75? No, this isn't an excuse to skip screening for colon cancer, which has been proven to save lives. But there are several ...
The Cologuard Plus test demonstrated 95% sensitivity for colorectal cancer detection at 94% specificity, making it the most accurate noninvasive CRC screening test reported in studies to date Building ...
The FDA approved Exact Sciences’ Cologuard Plus multitarget stool DNA test to screen adults aged 45 years or older at average risk for colorectal cancer, according to a company press release. Compared ...
Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded partnership with Humana Inc. to enhance access to colorectal cancer (CRC) ...
The Medicare Advantage Advanced Notice and Draft Call letter now includes Exact Sciences’ Cologuard. “The proposed inclusion of Cologuard in the Star Ratings program is an important step toward it ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback